The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia
- 1 January 2016
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 310 (1) , L59-L70
Abstract
Cystic fibrosis (CF), a genetic disease caused by mutations in the CFTR gene, is a life-limiting disease characterized by chronic bacterial airway infection and severe inflammation. Some CFTR mutants have reduced responsiveness to cAMP/PKA signaling; hence, pharmacological agents that elevate intracellular cAMP are potentially useful for the treatment of CF. By inhibiting cAMP breakdown, phosphodiesterase (PDE) inhibitors stimulate CFTR in vitro and in vivo. Here, we demonstrate that PDE inhibition by RPL554, a drug that has been shown to cause bronchodilation in asthma and chronic obstructive pulmonary disease (COPD) patients, stimulates CFTR-dependent ion secretion across bronchial epithelial cells isolated from patients carrying the R117H/F508del CF genotype. RPL554-induced CFTR activity was further increased by the potentiator VX-770, suggesting an additional benefit by the drug combination. RPL554 also increased cilia beat frequency in primary human bronchial epithelial cells. The results indicate RPL554 may increase mucociliary clearance through stimulation of CFTR and increasing ciliary beat frequency and thus could provide a novel therapeutic option for CF.Keywords
Funding Information
- Verona Pharma plc (G237806 Verona Pharma Inc.)
This publication has 64 references indexed in Scilit:
- CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activityJournal of Cell Science, 2012
- Adenosine activation of A2Breceptor(s) is essential for stimulated epithelial ciliary motility and clearanceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological FunctionsPhysiological Reviews, 2011
- Compartmentalized Cyclic Adenosine 3′,5′-Monophosphate at the Plasma Membrane Clusters PDE3A and Cystic Fibrosis Transmembrane Conductance Regulator into MicrodomainsMolecular Biology of the Cell, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences, 2009
- A2B Adenosine Receptors Regulate the Mucus Clearance Component of the Lung's Innate Defense SystemAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Characterization of an A-Kinase Anchoring Protein in Human Ciliary AxonemesMolecular Biology of the Cell, 2002
- Suppression of human inflammatory cell function by subtype‐selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4BBritish Journal of Pharmacology, 1999
- Multi-ion pore behaviour in the CFTR chloride channelNature, 1993
- Higher Bioelectric Potentials Due to Decreased Chloride Absorption in the Sweat Glands of Patients with Cystic FibrosisNew England Journal of Medicine, 1983